JHS Svendgaard Laboratories Limited (JHS) Price & Analysis

Compare

0 Followers

JHS Stock Chart & Stats

₹9.34

₹0.02(0.10%)

At close: Jan 08 4:00 PM EST

₹9.34

₹0.02(0.10%)

Day’s Range― - ―

52-Week Range₹8.72 - ₹16.20

Previous CloseN/A

Volume57.31K

Average Volume (3M)16.78K

Market Cap

₹760.16M

Enterprise Value₹708.12M

Total Cash (Recent Filing)₹195.43M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)27.3

Beta0.93

Next Earnings

Jun 02, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.09

Shares Outstanding85,603,966

10 Day Avg. Volume16,348

30 Day Avg. Volume16,781

Financial Highlights & Ratios

PEG Ratio-0.01

Price to Book (P/B)0.57

Price to Sales (P/S)1.06

P/FCF Ratio-6.22

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong Equity-heavy Balance SheetAn equity ratio of 85.83% and minimal debt (D/E 0.037) provide durable financial flexibility. This reduces bankruptcy risk, supports working-capital cushions and capacity maintenance, and allows the company to absorb operating losses or fund short-term investments without reliance on expensive leverage.

Contract Manufacturing Business ModelThe company's focus on contract manufacturing and private-label supply creates recurring, order-driven revenue and predictable plant utilization. Durable supplier-brand relationships improve capacity planning and provide steady demand for manufacturing output over the medium term, supporting revenue stability if customer contracts persist.

Improved Gross Profit MarginA higher gross margin (33.66% in 2025) signals improved cost control or better pricing power at the manufacturing level. Sustained gross-margin improvement increases the headroom to cover fixed costs and can materially shorten the path to operating break-even if SG&A and overhead remain controlled.

Bears Say

Persistent UnprofitabilityMulti-year losses and a -21.47% net margin in 2025 reflect structural profitability issues. Continued negative earnings erode retained equity, constrain reinvestment and R&D, and force management to prioritize cost cuts or external financing, limiting strategic flexibility over the next several quarters.

Negative Free Cash Flow And Weak Cash ConversionPersistent negative free cash flow and poor operating-cash conversion undermine liquidity and operational resilience. Reliance on financing inflows to cover cash shortfalls raises funding risk, can increase cost of capital, and constrains the firm's ability to invest in capacity or win larger contract manufacturing mandates.

Multi-year Revenue DeclineA material top-line decline through 2020–2025 signals loss of scale and demand erosion in core segments. Shrinking revenue undermines operating leverage, can increase unit costs, and makes it harder to maintain client relationships and margins, posing a structural headwind to recovery efforts.

JHS Svendgaard Laboratories Limited News

JHS Svendgaard Grants 250,000 Stock Options Under 2025 ESOP

JHS Svendgaard Laboratories Limited ( ($IN:JHS) ) has shared an announcement. JHS Svendgaard Laboratories Limited’s Nomination and Remuneration...

25d ago

JHS

JHS Svendgaard Completes Rs 3.75 Crore Preferential Allotment to Coeus Global Opportunities Fund

JHS Svendgaard Laboratories Limited ( ($IN:JHS) ) has provided an announcement. JHS Svendgaard Laboratories Limited has approved the...

1M ago

JHS

Exchange Seeks Clarification from JHS Svendgaard on September 2025 Quarterly Results

JHS Svendgaard Laboratories Limited ( ($IN:JHS) ) has provided an update. The stock exchange has sought clarification from...

2M ago

JHS

JHS Svendgaard Laboratories Releases Financial Results for September 2025

JHS Svendgaard Laboratories Limited ( ($IN:JHS) ) just unveiled an announcement. JHS Svendgaard Laboratories Limited has announced the...

4M ago

JHS

JHS Svendgaard Laboratories Holds 21st AGM Virtually

JHS Svendgaard Laboratories Limited ( ($IN:JHS) ) has shared an announcement. JHS Svendgaard Laboratories Limited conducted its 21st...

6M ago

JHS

JHS Svendgaard Laboratories Prepares for Virtual AGM with Shareholder Engagement

JHS Svendgaard Laboratories Limited ( ($IN:JHS) ) has shared an update. JHS Svendgaard Laboratories Limited announced the dispatch...

6M ago

JHS

JHS FAQ

What was JHS Svendgaard Laboratories Limited’s price range in the past 12 months?

JHS Svendgaard Laboratories Limited lowest stock price was ₹8.72 and its highest was ₹16.20 in the past 12 months.

What is JHS Svendgaard Laboratories Limited’s market cap?

JHS Svendgaard Laboratories Limited’s market cap is ₹760.16M.

When is JHS Svendgaard Laboratories Limited’s upcoming earnings report date?

JHS Svendgaard Laboratories Limited’s upcoming earnings report date is Jun 02, 2026 which is in 87 days.

How were JHS Svendgaard Laboratories Limited’s earnings last quarter?

JHS Svendgaard Laboratories Limited released its earnings results on Feb 10, 2026. The company reported ₹0.092 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.092.

Is JHS Svendgaard Laboratories Limited overvalued?

According to Wall Street analysts JHS Svendgaard Laboratories Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does JHS Svendgaard Laboratories Limited pay dividends?

JHS Svendgaard Laboratories Limited pays a Annually dividend of ₹0.75 which represents an annual dividend yield of N/A. See more information on JHS Svendgaard Laboratories Limited dividends here

What is JHS Svendgaard Laboratories Limited’s EPS estimate?

JHS Svendgaard Laboratories Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does JHS Svendgaard Laboratories Limited have?

JHS Svendgaard Laboratories Limited has 85,603,966 shares outstanding.

What happened to JHS Svendgaard Laboratories Limited’s price movement after its last earnings report?

JHS Svendgaard Laboratories Limited reported an EPS of ₹0.092 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.965%.

Which hedge fund is a major shareholder of JHS Svendgaard Laboratories Limited?

Currently, no hedge funds are holding shares in IN:JHS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

JHS Svendgaard Laboratories Limited

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture products under the Dr. Gold and Aquawhite brands. It also provides contract manufacturing services for oral care products of other brands; and operates retail stores at airports. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1996 and is based in New Delhi, India.